Replies to post #90514 on Cytodyn Inc (CYDY)

[Impailer]

Oh wow....great find, Bio.

[chumppunk]

BioInvestor4 - makes sense to have the USA supply/distribution question answered before approval USA wide. Lining up nice.
Chump

[Vegas Stocks]

Nice work again Bio !!!

[Venture_Cap]

How could this be leronlimab this early? They haven’t had a chance to review the data. Sounds like they have another therapeutic. OR... they already know the M/M data or midterm S/C... which is doubtful.

[SaraLovesYou]

I'm taking it back to bbcbro's post a week ago as to Trump's forthcoming 'therapeutics' announcement; IMO of course:

ACTIV is planning five master protocol trials, the first of which will test three host-targeted immune modulators against TNFa, CTLA-4 and CCR2/CCR5. The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) consortium is led by NIH and managed by the Foundation for NIH. Its members include 18 biopharma companies, FDA, CDC and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). BARDA is part of ASPR (see “ACTIV Coming into Focus”).

“Next week administration officials plan to promote a new study they say shows promising results on therapeutics, the officials said. They wouldn't describe the study in any further detail because, they said, its disclosure would be "market-moving”

https://www.google.com/amp/s/www.nbcnews.com/news/amp/ncna1232884